What is the Brand Less than Generic Program?
The Brand Less than Generic Program is a cost containment initiative which promotes the use of certain multi-source brand name drugs when the cost of the brand name drug is less expensive than the generic equivalent. Generic drugs included in this program require prior authorization. Products are identified on the Medicaid List of Reimbursable Drugs with a “C” in the “PA” code column (http://www.emedny.org/info/formfile.html.). Once it is determined that the generic drug is more cost-effective than the brand name equivalent, the prior authorization requirement will be removed for the generic drug. Please keep in mind that multi-source brand name drugs may be included in the Mandatory Generic Drug Program; again promoting the use of the most cost-effective product.
Related Questions
- What if I am currently taking a brand name maintenance medication that has a generic available and would be covered by the Generic Prescribing Program?
- Why did I receive a generic prescription through the home delivery program, when my doctor wrote the prescription for a brand drug?
- Aetna RX charges like price for brand drug Altace and Ramipril which is the Generic. Is this officially recognized?
